NCT06635226View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

June 19, 2025

Study Completion Date

June 19, 2025

Conditions
Healthy Adult Subjects
Interventions
DRUG

ID110521156

ID110521156 capsules taken orally once daily

DRUG

Placebo of 110521156

ID110521156 placebo capsules taken orally once daily

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
collaborator

YUNOVIA CO.,LTD.

UNKNOWN

lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT06635226 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter